Skip to main content

Advertisement

Log in

Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Secondary and tertiary cytoreductive surgery was associated with improved overall survival in platinum-sensitive recurrent ovarian cancer (ROC). Hyperthermic intraoperative intra-peritoneal chemotherapy (HIPEC) is considered an attractive method in the treatment of ROC to deliver chemotherapy with enhanced effect directly at the tumor site. However, another deserving aspect is the feasibility and the oncologic role of HIPEC repetition. Twelve patients affected by secondary ovarian cancer recurrence previously submitted to cytoreduction followed by HIPEC were enrolled for the present study to receive tertiary cytoreduction followed by HIPEC repetition. The median operative time, including time for HIPEC procedure, was 360 min (range 240–540). Average EBL was 325 ml (from 100 to 500 ml). The median hospital stay was of 5 days, from 4 to 10. Low-grade post operatory complications occurred in 2 patients (16.6%) and high-grade complication in 1 case (8.3%). Our study report encouraging data about safety of HIPEC repetition in ovarian cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Laganà AS, Vitale SG, Trovato MA et al (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179. https://doi.org/10.1155/2016/3617179

    Article  PubMed  PubMed Central  Google Scholar 

  2. Caruso S, Cianci S, Vitale SG et al (2017) Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse. Menopause 24:900–907. https://doi.org/10.1097/GME.0000000000000851

    Article  PubMed  Google Scholar 

  3. Caruso S, Rugolo S, Bandiera S et al (2007) Clitoral blood flow changes after surgery for stress urinary incontinence: pilot study on TVT versus TOT procedures. Urology 70:554–557. https://doi.org/10.1016/j.urology.2007.04.045

    Article  PubMed  Google Scholar 

  4. Lagana AS, Vitale SG, De Dominici R et al (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy a 12-years retrospective cohort study. Ann Ital Chir 87:461–465

    PubMed  Google Scholar 

  5. Vitale SG, Laganà AS, Gulino FA et al (2016) Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg 68:325–329. https://doi.org/10.1007/s13304-015-0343-y

    Article  PubMed  Google Scholar 

  6. Vitale SG, Sapia F, Rapisarda AMC et al (2017) Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int 2017:6848250. https://doi.org/10.1155/2017/6848250

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sturlese E, Triolo O, Grasso R et al (2017) Thromboembolism prophylaxis in laparoscopic surgery for gynecologic benign diseases. Results of a single center experience in 922 procedures. Ann Ital Chir 88:342–347

    PubMed  Google Scholar 

  8. Di Sardo Spiezio A, Vieira MDC, Laganà AS et al (2017) Combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eurasian J Med 49:66–68. https://doi.org/10.5152/eurasianjmed.2017.16215

    Article  Google Scholar 

  9. Di Sardo Spiezio A, Di Guardo F, Santangelo F, Cianci S, Giampaolino P (2017) Commentary on “Assessment of risk factors of intrauterine adhesions in patients with induced abortion and the curative effect of hysteroscopic surgery”. J Investig Surg 18:1–3. https://doi.org/10.1080/08941939.2017.1400133

    Article  Google Scholar 

  10. Bellia A, Vitale SG, Laganà AS, Cannone F, Houvenaeghel G, Rua S, Ladaique A, Jauffret C, Ettore G, Lambaudie E (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294(3):615–622

    Article  PubMed  Google Scholar 

  11. Cignini P, Vitale SG, Laganà AS, Biondi A, La Rosa VL, Cutillo G (2017) Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 69(1):75–82

    Article  PubMed  Google Scholar 

  12. Rossetti D, Vitale SG, Tropea A, Biondi A, Laganà AS (2017) New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer. Updates Surg 69(3):383–388

    Article  PubMed  Google Scholar 

  13. Tozzi R, Giannice R, Cianci S et al (2015) Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral–Peritoneal Debulking (VPD) in patients with stage IIIC–IV ovarian cancer. Gynecol Oncol 138:252–258. https://doi.org/10.1016/j.ygyno.2015.05.010

    Article  PubMed  Google Scholar 

  14. Gueli Alletti S, Rossitto C, Cianci S, Scambia G (2016) Telelap ALF-X total hysterectomy for early stage endometrial cancer: new frontier of robotic gynecological surgery. Gynecol Oncol 140:575–576. https://doi.org/10.1016/j.ygyno.2016.01.018

    Article  CAS  PubMed  Google Scholar 

  15. Gueli Alletti S, Rossitto C, Cianci S et al (2016) Telelap ALF-X vs standard laparoscopy for the treatment of early-stage endometrial cancer: a single-institution retrospective cohort study. J Minim Invasive Gynecol 23:378–383. https://doi.org/10.1016/j.jmig.2015.11.006

    Article  PubMed  Google Scholar 

  16. Gueli Alletti S, Rossitto C, Perrone E et al (2017) Needleoscopic conservative staging of borderline ovarian tumor. J Minim Invasive Gynecol 24:529–530. https://doi.org/10.1016/j.jmig.2016.10.009

    Article  PubMed  Google Scholar 

  17. Chiofalo B, Palmara V, Laganà AS et al (2017) Fertility sparing strategies in patients affected by placental site trophoblastic tumor. Curr Treat Options Oncol 18:58. https://doi.org/10.1007/s11864-017-0502-0

    Article  PubMed  Google Scholar 

  18. Vitale SG, La Rosa VL, Rapisarda AMC, Lagana AS (2017) The importance of fertility preservation counseling in patients with gynecologic cancer. J Reprod Infertil 18:261–263

    PubMed  PubMed Central  Google Scholar 

  19. Vitale SG, La Rosa VL, Rapisarda AMC et al (2018) Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil (Camb) 21:35–38. https://doi.org/10.1080/14647273.2017.1339365

    Article  Google Scholar 

  20. Laganà AS, La Rosa VL, Rapisarda AMC et al (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11:ed62. https://doi.org/10.3332/ecancer.2017.ed62

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gueli Alletti S, Vizzielli G, Lafuenti L, Costantini B, Fagotti A, Fedele C, Cianci S, Perrone E, Gallotta V, Rossitto C, Scambia G (2018) Single-institution propensity-matched study to evaluate the psychological effect of minimally invasive interval debulking surgery versus standard laparotomic treatment: from body to mind and back. J Minim Invasive Gynecol 25(5):816–822

    Article  PubMed  Google Scholar 

  22. Laganà AS, La Rosa VL, Rapisarda AMC et al (2017) Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health 9:323–330. https://doi.org/10.2147/IJWH.S119729

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2017) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol 38:317–319. https://doi.org/10.1080/0167482X.2016.1244185

    Article  PubMed  Google Scholar 

  24. Rossitto C, Gueli Alletti S, Rotolo S et al (2016) Total laparoscopic hysterectomy using a percutaneous surgical system: a pilot study towards scarless surgery. Eur J Obstet Gynecol Reprod Biol 203:132–135. https://doi.org/10.1016/j.ejogrb.2016.05.007

    Article  PubMed  Google Scholar 

  25. Gueli Alletti S, Rossitto C, Cianci S et al (2018) The SenhanceTM surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study. J Robot Surg 12:229–234. https://doi.org/10.1007/s11701-017-0718-9

    Article  PubMed  Google Scholar 

  26. Gueli Alletti S, Perrone E, Cianci S et al (2018) 3 mm Senhance robotic hysterectomy: a step towards future perspectives. J Robot Surg. https://doi.org/10.1007/s11701-018-0778-5

    Article  PubMed  Google Scholar 

  27. Rossitto C, Cianci S, Gueli Alletti S et al (2017) Laparoscopic, minilaparoscopic, single-port and percutaneous hysterectomy: comparison of perioperative outcomes of minimally invasive approaches in gynecologic surgery. Eur J Obstet Gynecol Reprod Biol 216:125–129. https://doi.org/10.1016/j.ejogrb.2017.07.026

    Article  CAS  PubMed  Google Scholar 

  28. Cosentino F, Vizzielli G, Turco LC et al (2018) Near-infrared imaging with indocyanine green for detection of endometriosis lesions (Gre-Endo Trial): a pilot study. J Minim Invasive Gynecol. https://doi.org/10.1016/j.jmig.2018.02.023

    Article  PubMed  Google Scholar 

  29. Rapisarda AMC, Cianci A, Caruso S et al (2018) Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch Gynecol Obstet 297:1353–1375. https://doi.org/10.1007/s00404-018-4728-2

    Article  PubMed  Google Scholar 

  30. Gallotta V, Conte C, Giudice MT et al (2017) Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience. J Minim Invasive Gynecol 25:644–650. https://doi.org/10.1016/j.jmig.2017.10.024

    Article  PubMed  Google Scholar 

  31. Fagotti A, Costantini B, Gallotta V et al (2015) Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. J Minim Invasive Gynecol 22:428–432. https://doi.org/10.1016/j.jmig.2014.11.008

    Article  PubMed  Google Scholar 

  32. Fanfani F, Fagotti A, Ercoli A et al (2015) Is there a role for tertiary (TCR) and quaternary (QCR) cytoreduction in recurrent ovarian cancer? Anticancer Res 35:6951–6955

    PubMed  Google Scholar 

  33. Bristow RE, Puri I, Chi DS (2009) Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 112:265–274. https://doi.org/10.1016/j.ygyno.2008.08.033

    Article  PubMed  Google Scholar 

  34. Petrillo M, De Iaco P, Cianci S et al (2016) Long-term survival for platinum-sensitive recurrent ovarian cancer patients treated with secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1660–1665. https://doi.org/10.1245/s10434-015-5050-x

    Article  CAS  PubMed  Google Scholar 

  35. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41. https://doi.org/10.1159/000180580

    Article  CAS  PubMed  Google Scholar 

  36. Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  38. Issels RD (2008) Hyperthermia adds to chemotherapy. Eur J Cancer 44:2546–2554. https://doi.org/10.1016/j.ejca.2008.07.038

    Article  CAS  PubMed  Google Scholar 

  39. Fagotti A, Costantini B, Vizzielli G et al (2011) HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome. Gynecol Oncol 122:221–225. https://doi.org/10.1016/j.ygyno.2011.04.008

    Article  PubMed  Google Scholar 

  40. Cianci S, Vizzielli G, Fagotti A et al (2018) A novel HIPEC technique using hybrid CO2 recirculation system: intra-abdominal diffusion test in a porcine model. Updates Surg. https://doi.org/10.1007/s13304-018-0557-x

    Article  PubMed  Google Scholar 

  41. Cianci S, Abatini C, Fagotti A et al (2018) Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center. Updates Surg. https://doi.org/10.1007/s13304-018-0578-5

    Article  PubMed  Google Scholar 

  42. Paris I, Cianci S, Vizzielli G et al (2018) Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer. Int J Hyperth. https://doi.org/10.1080/02656736.2018.1503346

    Article  Google Scholar 

  43. Falcone F, Scambia G, Benedetti Panici P et al (2017) Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: a multicentre MITO retrospective study. Gynecol Oncol 147:66–72. https://doi.org/10.1016/j.ygyno.2017.07.008

    Article  CAS  PubMed  Google Scholar 

  44. Vitale SG, Caruso S, Rapisarda AMC et al (2018) Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study. Prz Menopauzalny 17:32–38. https://doi.org/10.5114/pm.2018.73791

    Article  PubMed  PubMed Central  Google Scholar 

  45. Caruso S, Cianci S, Fava V et al (2018) Vaginal health of postmenopausal women on nutraceutical containing equol. Menopause 25:430–435. https://doi.org/10.1097/GME.0000000000001061

    Article  PubMed  Google Scholar 

  46. Caruso S, Cianci S, Cariola M et al (2017) Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17β-Estradiol. J Womens Health (Larchmt) 26:728–734. https://doi.org/10.1089/jwh.2016.5801

    Article  Google Scholar 

  47. Caruso S, Cianci S, Cariola M et al (2017) Effects of nutraceuticals on quality of life and sexual function of perimenopausal women. J Endocrinol Investig 40:27–32. https://doi.org/10.1007/s40618-016-0500-2

    Article  CAS  Google Scholar 

  48. Caruso S, Rapisarda AM, Cianci S (2016) Sexuality in menopausal women. Curr Opin Psychiatry 29:323–330. https://doi.org/10.1097/YCO.0000000000000280

    Article  PubMed  Google Scholar 

  49. Caruso S, Cianci S, Amore FF et al (2016) Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Menopause 23:47–54. https://doi.org/10.1097/GME.0000000000000485

    Article  PubMed  Google Scholar 

  50. Caruso S, Agnello C, Malandrino C et al (2014) Do hormones influence women’s sex? Sexual activity over the menstrual cycle. J Sex Med 11:211–221. https://doi.org/10.1111/jsm.12348

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The work was not supported by any fund/Grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Cianci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

All procedures performed in studies involving animals were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all subjects.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cianci, S., Ronsini, C., Vizzielli, G. et al. Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence. Updates Surg 71, 389–394 (2019). https://doi.org/10.1007/s13304-018-0600-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-018-0600-y

Keywords

Navigation